Articles From: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2014 to Mesa Labs Reports 46% Increase in First Quarter Revenues


SOUTH JORDAN, Utah, July 16, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI) , a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the second quarter ended June 30, 2014, after the close of the stock market on Tuesday, July 29 th , 2014.
Sign-up for Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2014 investment picks
SOUTH JORDAN, Utah, Aug.
Sign-up for Merit Medical to Present at Canaccord Genuity Growth Conference investment picks
SOUTH JORDAN, Utah, Sept.
Sign-up for Merit Medical to Present at CL King Conference investment picks
Deployment of virtual tape solution helps maintain sustainable IT operations AUSTIN, Texas , Aug.
Sign-up for Meritage Homes Boosts Data Protection with Crossroads SPHiNX investment picks
Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, announced today that the company has created a new South Region to be based in Atlanta.
Sign-up for Meritage Homes Names James Thrower Region President of Its Newly Formed South Region investment picks
Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, today announced second quarter results for the period ended June 30, 2014.
Sign-up for Meritage Homes Reports Results for the Second Quarter of 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1127197&ProfileId=051205&sourceType=1 SCOTTSDALE, AZ --
Sign-up for Meritage Homes Second Quarter 2014 Earnings Release and Webcast Conference Call Scheduled for July 24, 2014 investment picks
Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, today announced its definitive agreement to acquire the homebuilding assets and operations of Atlanta-based Legendary Communities for a purchase price of approximately $130 million.
Sign-up for Meritage Homes to Acquire Legendary Communities, Expanding Its Southeast Operations investment picks
Intends to Use Settlement Net Proceeds to Fund Global Pension Plans and Strengthen Balance Sheet Board of Directors Authorizes $210 Million Equity Repurchase Program to be Funded by a Portion of Future Free Cash Flow TROY, Mich.
Sign-up for Meritor Reaches Agreement with Eaton Corporation to Settle Antitrust Lawsuit investment picks
Raises Fiscal Year 2014 Earnings and Free Cash Flow Guidance TROY, Mich.
Sign-up for Meritor Reports Third-Quarter Fiscal Year 2014 Results investment picks
TROY, Mich.
Sign-up for Meritor to Present at Jefferies Global Industrials Conference investment picks
2014/8/6
Merlin, the global rights agency for the independent label sector, and Pandora (NYSE:P), the leading internet radio service, today announced a comprehensive partnership designed to help independent labels and artists grow the audiences they reach and the royalties they receive.
Sign-up for Merlin and Pandora Partner to Help Independent Labels and Artists Grow Their Businesses investment picks
2014/6/16
By Tess Stynes and Matthias Rieker The Financial Industry Regulatory Authority said Merrill Lynch will pay $32.4 million to settle allegations the Bank of America Corp.
Sign-up for Merrill fined for alleged failure to waive fees investment picks
CAMBRIDGE, Mass., June 17, 2014 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that results of the successful Phase 3 NAPOLI-1 study in metastatic pancreatic cancer will be communicated in an oral presentation at the European Society for Medical Oncology 16 th World Congress on Gastrointestinal Cancer (ESMO GI) held from June 25th to 28th, 2014 at The International Convention Center of Barcelona in Barcelona, Spain.
Sign-up for Merrimack Pharmaceuticals Announces Oral Presentation of Additional Data Results in Phase 3 NAPOLI-1 Study at the ESMO 16th World Congress on Gastrointestinal Cancer investment picks
CAMBRIDGE, Mass., Aug.
Sign-up for Merrimack Pharmaceuticals Announces Timing of Second Quarter 2014 Investor Conference Call investment picks
MM-398 in combination with 5-fluorouracil and leucovorin shows statistically significant improvement in overall survival, progression free survival and overall response rate in patients with post-gemcitabine metastatic pancreatic cancer CAMBRIDGE, Mass., June 25, 2014 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced detailed results from NAPOLI-1, a large, randomized, three-arm Phase 3 study of MM-398, a nanoliposomal encapsulation of irinotecan, in patients with metastatic pancreatic cancer previously treated with gemcitabine-based therapy.
Sign-up for Merrimack Pharmaceuticals Presents Data From Phase 3 NAPOLI-1 Study at the ESMO 16th World Congress on Gastrointestinal Cancer investment picks
CAMBRIDGE, Mass., Aug.
Sign-up for Merrimack Pharmaceuticals Reports Second Quarter 2014 Financial Results investment picks
Merrimack to Pursue Registration Path for MM-121 and Partnership Opportunities CAMBRIDGE, Mass., June 19, 2014 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that it has reached an agreement with Sanofi to regain worldwide rights to develop and commercialize MM-121, a monoclonal antibody designed to block ErbB3 (HER3) activation in patients with heregulin-positive tumors and improve response to standard of care treatments.
Sign-up for Merrimack Pharmaceuticals to Regain Worldwide Rights to Develop and Commercialize MM-121 investment picks
http://media.marketwire.com/attachments/201308/176784_59635_Meru_Logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1139550&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Meru Networks First to Achieve Microsoft Lync Qualification for 802.11ac Wi-Fi Solutions investment picks
- Revenues grew 14% sequentially - 802.11ac sales grew 63% sequentially - Meru Networks first to receive OPENFLOW SDN certification for wireless networking SUNNYVALE, Calif.
Sign-up for Meru Networks Reports Q2 2014 Financial Results investment picks
SUNNYVALE, Calif.
Sign-up for Meru Networks To Report Second Quarter 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961637001&sourceType=1 TORONTO, ONTARIO --
Sign-up for Merus Labs International Inc. Subsidiary Signs Product Acquisition Letter of Intent investment picks
Federal Aviation Administration Grants a Certificate of Authorization for the Trimble UX5 Aerial Imaging Solution SUNNYVALE, Calif.
Sign-up for Mesa County Colorado Obtains Authorization to Operate Trimble's Unmanned Aircraft System investment picks
LAKEWOOD, Colo., July 17, 2014 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.15 per share of common stock.
Sign-up for Mesa Labs Declares Quarterly Dividend investment picks
LAKEWOOD, Colo., Aug.
Sign-up for Mesa Labs Reports 46% Increase in First Quarter Revenues investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2014 to Mesa Labs Reports 46% Increase in First Quarter Revenues
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices